Open Access

Fat mass and fat distribution are associated with low back pain intensity and disability: results from a cohort study

Contributed equally
Arthritis Research & Therapy201719:26

https://doi.org/10.1186/s13075-017-1242-z

Received: 15 November 2016

Accepted: 23 January 2017

Published: 10 February 2017

Abstract

Background

Determining the association between body composition and low back pain (LBP) will improve our understanding of the mechanisms by which obesity affects LBP, and inform novel approaches to managing LBP. The aim of this study was to examine the relationship between body composition and LBP intensity and disability.

Methods

A total of 5058 participants (44% men) of the Australian Diabetes, Obesity and Lifestyle Study were assessed for LBP intensity and disability using the Chronic Pain Grade Questionnaire (2013–2014). Body mass index (BMI) and waist circumference were directly obtained. Fat mass and percentage fat were estimated from bioelectrical impedance analysis at study inception (1999–2000).

Results

Eighty-two percent of participants reported LBP, of whom 27% also reported LBP disability. BMI, waist circumference, percent fat, and fat mass were each positively associated with LBP intensity and disability at 12 years after adjustment for potential confounders. LBP intensity and disability showed significant dose-responses to sex-specific quartiles of BMI, waist circumference, percent fat and fat mass. For example, the adjusted OR for LBP intensity in women increased with increasing fat mass quartiles [Q1: 1, Q2: 1.05 (95%CI 0.84–1.32); Q3: 1.25 (1.00–1.57); and Q4: 1.78 (1.42–2.24); p < 0.001].

Conclusions

Fat mass and distribution are associated with LBP intensity and disability, suggesting systemic metabolic factors associated with adiposity play a major role in the pathogenesis of LBP. Clarifying the mechanisms will facilitate developing novel preventive and therapeutic approaches for LBP.

Keywords

Obesity Body composition Fat mass Fat-free mass Low back pain

Background

Low back pain (LBP) contributed the highest years lived with disability among a total of 291 conditions investigated in the Global Burden of Disease 2010 study, resulting in 83 million years lived with disability [1]. One in ten people suffer from LBP worldwide at any point in time [1, 2] and 70–85% of people have a LBP episode at some time in their life [2]. There has been an increase in disability, chronicity and work absenteeism attributable to this condition [3], which has had an enormous negative economic impact on individuals, families, communities, industries and governments [2, 4]. As such, understanding the aetiology and risk factors for LBP is important in reducing the significant burden accountable to this condition.

The prevalence of overweight and obesity that has contributed to 3.4 million deaths in 2010 is escalating in many countries and has been labelled as a global pandemic [5]. Overweight and obesity are associated with several musculoskeletal diseases including LBP. A systematic review [6] and afterwards a meta-analysis [7] of data from small cross-sectional and prospective cohort studies showed that both overweight and obesity increased the risk of LBP. These findings were supported by the large population-based Nord-Trøndelag Health (HUNT) Study that included over 25,000 participants [8]. Most of the studies included in the meta-analysis used body mass index (BMI) cutoff points to define overweight and obesity, while some studies used body weight and a few studies used waist circumference in combination with waist to hip ratio [7]. However, no studies in the systematic review or the meta-analysis examined fat mass or distribution.

Although obesity is a risk factor for LBP in adults, the mechanism is unclear. Most research has used weight and BMI as a measure of obesity. However, these measures do not take into account body composition i.e. fat and muscle mass. There is increasing evidence for a differential effect of fat and muscle on the risk of musculoskeletal diseases [9, 10]. For instance, there are negative effects of excess adiposity on movement patterns and on body structure [11, 12] that contribute to different disabilities including LBP. Two previous cross-sectional studies examining the association between body composition and LBP have suggested an effect of fat mass on LBP. One study of 135 participants (83.1% women) found that greater fat mass, but not lean tissue mass, was associated with high levels of LBP intensity and disability [13]. A Spanish study of 1128 twin women, with 38% unavailable data on fat mass, reported a weak association of fat percent and fat mass with LBP which was confounded by genetic and early shared environmental factors [14]. Neither of these studies had longitudinal data. Similarly, both the studies included women only [14] or women mostly [13]. However, men and women differ substantially in regard to body composition, especially adipose tissue distribution [15, 16]. Determining the gender-specific effect of body composition on LBP has the potential to improve our understanding of the mechanisms by which obesity affects LBP in men and women, and thus has the potential to provide novel approaches to managing this condition. Therefore the aim of this study was to examine the relationship between gender-specific body composition and LBP intensity and disability longitudinally in a national, population-based cohort of men and women.

Methods

Study participants

The Australian Diabetes, Obesity and Lifestyle (AusDiab) Study is a national, population-based cohort study of 11,247 people, aged ≥25 years, recruited by a stratified cluster sampling method, involving seven strata (six states and the Northern Territory) and clusters based on census collector districts, during 1999–2000 [17]. AusDiab participants were followed up during 2004–2005 and then again in 2011–2012. Of the 11,247 participants, 3472 were excluded as they were ineligible for further contact (requested no further contact, deceased, too ill or living in high care nursing facility). In the back pain sub-study, 7775 participants were sent the back pain questionnaire between February 2013 and October 2014, of whom 5058 responded (response rate 65.1%, Fig. 1) and were included in the study. The participants who responded to the LBP questionnaire were younger, more educated, had a higher Index of Relative Disadvantage code from the Socio-Economic Indexes for Areas (SEIFA), lower BMI and waist circumference compared to those who did not respond. There was no difference in relation to body composition measures among those who responded to the LBP questionnaire and those who did not (Additional file 1: Table S1).
Fig. 1

Flow diagram of recruited participants

Demographic, lifestyle factors, and socio-economic position assessments

Demographic and lifestyle data, including date of birth, gender, education, smoking (current, ex- or never), and leisure time physical activity (minutes per week), were collected in 1999–2000 by trained interviewers using standardised questionnaires as reported previously [17]. The Short Form 36 (SF-36), a self-administered questionnaire which measures mental and emotional conditions of a person [18, 19], was used to determine the physical (PCS) and mental health component summary (MCS) scores, and bodily pain. Socio-economic indexes for areas were estimated using the SEIFA [20]. The index is constructed such that high values reflect areas with high socio-economic position (relative advantage) and low values reflect areas with low socio-economic position (relative disadvantage).

Obesity and body composition measurements

Data regarding obesity and body composition were measured at baseline during 1999–2000, first follow-up during 2004–2005 and second follow-up during 2011–2012. Height was measured to the nearest 0.5 cm without shoes using a stadiometer. Weight was measured without shoes and in light clothing to the nearest 0.1 kg using a mechanical beam balance. BMI was calculated as weight in kilograms divided by height in meters squared [17]. Waist circumference was measured to the nearest 1 mm using a metal anthropometric tape [21]. Fat mass was assessed by bio-impedance, using the Tanita body fat analyser (Model TBF-105, Tanita Corporation, Tokyo, Japan), which calculates body fat as a function of sex, height, weight and impedance [17, 22]. Fat percentage was calculated as fat mass divided by weight.

Categorisation of back pain intensity and disability

The self-administered Chronic Pain Grade Questionnaire (CPGQ) was used to obtain information on LBP intensity and disability over the past 6 months (Additional file 2). This is a reliable and valid instrument for use in population surveys of LBP [13, 23, 24]. The questionnaire includes seven questions from which a pain intensity score (0–100) and disability points score (0–6) were calculated. To examine the relationship between pain intensity and various participant characteristics, subjects were classified into three groups based on their pain intensity score: no pain (=0), low pain intensity (<50), and high pain intensity (≥50). Similarly, to investigate risk factors for disability, subjects were categorized into three groups on the basis of their disability points score: no disability (=0), low disability (<3), and high disability (≥3) as previously described [13, 23, 24].

Statistical analysis

Independent samples t tests for continuous variables or chi-squared tests for categorical variables were used to compare the characteristics of participants with and without LBP (LBP intensity and disability). The persistence of obesity and body composition measures were measured between baseline and first follow-up during 2004–2005. Multinomial logistic regression models were used to estimate the odds ratio (OR) with 95% confidence level (CI) for each level of LBP intensity and disability associated with each obesity and body composition measure as continuous variables. Each obesity and body composition measure was further categorized into quartiles according to their sex-specific baseline distribution. Their associations with LBP intensity and disability were analysed using ordinal logistic regression, with the lowest quartile used as the referent category. All the analysis is adjusted for age, education, smoking status, SEIFA (model 1) and further adjusted for the MCS of SF-36 in model 2. There was an additional adjustment for fat-free mass in the models where waist circumference was the explanatory variable. Furthermore, fat mass and fat-free mass were adjusted for each other. Owing to the importance of physical activity in body composition, physical activity was further adjusted in additional models with other variables. Similarly, to overcome the change in obesity and body composition measures over time further adjustment were made (n = 3032). Analysis were repeated on participants who did not have bodily pain at baseline (n = 3961). All statistical analyses were performed using Stata 14.0 (StataCorp LP., College Station, TX, USA).

Results

The characteristics of the participants are presented in Table 1. The prevalence of low-intensity LBP was 62% (n = 3085) and high-intensity LBP was 20% (n = 1001). Most of the participants had no LBP disability 73% (n = 3061), while 16% (n = 651) reported low disability and 11% (n = 482) high disability. Participants with high LBP intensity or disability were likely to be older, less educated, current smokers, from lower SEIFA and scored lower in the SF-36 MCS component compared to those who had no LBP intensity and disability. All obesity and body composition measurements were greater in those with LBP intensity or disability compared with those without LBP symptoms. All the obesity measures (BMI, waist circumference) and body composition measures (percent fat, fat mass and muscle mass) are highly correlated at baseline and at first follow-up (correlation coefficient >0.89, p = <0.001) (Additional file 1: Table S2).
Table 1

General characteristics of participants

Low back pain intensitya

 

No intensity

n = 900

Low intensity

n = 3085

P

No vs low

High intensity

n = 1001

P

No vs high

Age at baseline, years

48.8 (11.1)

47.3 (10.9)

0.001

51.1 (11.8)

<0.001

Female, n (%)

497 (55.2)

1682 (54.6)

0.75

598 (60.1)

0.03

Current smoker, n (%)

89 (10.1)

357 (11.2)

0.26

182 (18.6)

<0.001

University degree, n (%)

354 (39.6)

1175 (38.4)

0.54

226 (22.9)

<0.001

SEIFA (in lowest tertile), n (%)

258 (29.2)

918 (30.3)

0.86

397 (40.4)

<0.001

MCS (SF-36)

51.0 (8.5)

48.9 (9.6)

<0.001

46.3 (11.2)

<0.001

BMI, kg/m2

26.0 (4.7)

26.6 (4.8)

<0.001

27.8 (5.3)

<0.001

Waist circumference, cm

87.9 (13.7)

89.5 (13.7)

0.002

92.7 (14.3)

<0.001

Percent of fat (%)

31.7 (11.8)

32.6 (11.6)

0.03

36.2 (13.3)

<0.001

Fat mass, kg

24.3 (12.4)

25.7 (12.4)

0.004

29.1 (14.6)

<0.001

Fat-free mass, kg

50.6 (11.8)

51.4 (12.2)

0.10

49.3 (12.6)

0.03

Low back pain disabilityb

 

No disability

n = 3,061

Low disability

n = 651

P

No vs low

High disability

n = 482

P

No vs high

Age at baseline, years

46.5 (10.7)

47.7 (11.5)

0.01

51.4 (10.9)

<0.001

Female, n (%)

1650 (54.0)

352 (54.2)

0.94

61.6 (61.2)

0.002

Current smoker, n (%)

335 (11.1)

97 (15.6)

0.01

108 (23.1)

<0.001

University degree, n (%)

1244 (41.0)

233 (36.1)

0.02

98 (20.6)

<0.001

SEIFA (in lowest tertile), (%)

888 (29.5)

212 (33.0)

0.20

194 (41.0)

<0.001

MCS (SF-36)

49.3 (9.2)

47.2 (10.6)

<0.001

46.2 (11.7)

<0.001

BMI, kg/m2

26.3 (4.7)

27.2 (5.0)

<0.001

28.6 (5.8)

<0.001

Waist circumference, cm

88.7 (13.5)

91.2 (13.4)

<0.001

94.1 (14.9)

<0.001

Percent of fat (%)

32.1 (11.5)

33.7 (12.6)

0.001

37.4 (13.3)

<0.001

Fat mass, kg

25.0 (12.5)

27.2 (14.0)

<0.001

30.6 (14.9)

<0.001

Fat-free mass, kg

51.4 (12.3)

51.4 (12.3)

0.95

49.1 (12.5)

<0.001

SEIFA Socio-Economic Indexes for Areas, MCS mental component score, BMI body mass index

aData were missing for 72 participants

bData were missing for 864 participants

Table 2 shows the association of LBP intensity with all anthropometric measures in men and women. All the obesity measures including BMI, waist circumference and body composition measures (percent fat, fat mass) were positively associated with LBP intensity and disability in both men and women after adjustment for age, education, smoking status, SEIFA and MCS of SF-36 (fat mass and fat-free mass were adjusted for each other). The associations between adiposity measures and high-intensity LBP were stronger than with lower-intensity LBP. Fat-free mass was negatively associated with LBP intensity only in women (low-intensity LBP: OR 0.72, 95% CI 0.54–0.96; high-intensity LBP: OR 0.75, 95% CI 0.56–1.01; p for between group variability <0.001 (low vs high intensity). The association did not change after introducing physical activity to the model (data not shown).
Table 2

Relationship between obesity and body composition and intensity of low back pain

 

Male

Female

Number

Low-intensity pain

High-intensity pain

P between group

Number

Low-intensity pain

High-intensity pain

P between group

OR (95% CI)

OR (95% CI)

variability (low/high)

 

OR (95% CI)

OR (95% CI)

variability (low/high)

Model 1

 Obesity measures

  BMI (per 5 kg/m2)

1

1.24 (1.07–1.44)

1.42 (1.18–1.71)

0.08

1

1.17 (1.05–1.30)

1.43 (1.26–1.62)

<0.001

  Waist circumference (per 10 cm)a

1

1.11 (0.98–1.26)

1.26 (1.08–1.47)

0.02

1

1.14 (1.04–1.25)

1.38 (1.24–1.54)

<0.001

 Body composition measures

  Percent fat (per 10%)

1

1.27 (1.08–1.49)

1.45 (1.20–1.76)

0.06

1

1.11 (1.00–1.23)

1.41 (1.25–1.59)

<0.001

  Fat mass (per 10 kg)a

1

1.10 (0.96–1.26)

1.22 (1.04–1.42)

0.01

1

1.10 (1.01–1.19)

1.28 (1.16–1.41)

<0.001

  Fat-free mass (per 10 kg)a

1

1.20 (0.98–1.48)

1.20 (0.93–1.56)

0.69

1

1.18 (0.94–1.48)

0.72 (0.54–0.96)

<0.001

Model 2

 Obesity measures

  BMI (per 5 kg/m2)

1

1.25 (1.07–1.45)

1.41 (1.17–1.70)

0.01

1

1.17 (1.05–1.30)

1.39 (1.22–1.59)

<0.001

  Waist circumference (per 10 cm)a

1

1.11 (0.98–1.27)

1.25 (1.07–1.46)

0.06

1

1.13 (1.03–1.24)

1.36 (1.22–1.52)

<0.001

 Body composition measures

  Percent fat (per 10%)

1

1.28 (1.09–1.51)

1.45 (1.19–1.77)

0.01

1

1.41 (1.25–1.59)

1.39 (1.22–1.57)

<0.001

  Fat mass (per 10 kg)b

1

1.11 (0.97–1.27)

1.23 (1.05–1.44)

0.18

1

1.28 (1.16–1.41)

1.27 (1.15–1.40)

<0.001

  Fat-free mass (per 10 kg)b

1

1.19 (0.97–1.47)

1.15 (0.88–1.50)

0.77

1

0.72 (0.54–0.96)

0.75 (0.56–1.01)

<0.001

Model 1: adjusted for age, education, smoking status, Socio-Economic Indexes for Areas (SEIFA), model 2: all the variables in model 1 and mental component score of SF-36

OR odds ratio, CI confidence level, BMI body mass index

aAdjusted for fat-free mass

bCo-adjusted for each other

The association of LBP disability with all obesity and body composition measures is shown in Table 3. Similar negative associations for all the obesity measures and body composition measures except fat-free mass were observed for LBP disability in both men and women after adjustment for age, education, smoking status, SEIFA and MCS of SF-36 (fat mass and fat-free mass were adjusted for each other). The association did not change after introducing physical activity or change in obesity and body composition measures to the model (data not shown).
Table 3

Relationship between obesity and body composition and low back disability

 

Male

Female

Number

Low disability

OR (95% CI)

High disability

OR (95% CI)

P between -group variability (low/high)

Number

Low disability

OR (95% CI)

High disability

OR (95% CI)

P between group variability (low/high)

Model 1

 Obesity measures

  BMI (per 5 kg/m2)

1

1.04 (0.88–1.22)

1.44 (1.20–1.74)

0.002

1

1.25 (1.13–1.39)

1.49 (1.33–1.66)

0.01

  Waist circumference (per 10 cm)a

1

1.15 (1.00–1.32)

1.36 (1.17–1.61)

0.05

1

1.23 (1.12–1.35)

1.39 (1.27–1.54)

0.03

 Body composition measures

  Percent fat (per 10%)

1

1.12 (0.94–1.34)

1.42 (1.14–1.77)

0.05

1

1.21 (1.08–1.35)

1.52 (1.35–1.72)

0.002

  Fat mass (per 10 kg)b

1

1.08 (0.94–1.24)

1.30 (1.11–1.52)

0.03

1

1.18 (1.09–1.28)

1.34 (1.23–1.47)

0.02

  Fat-free mass (per 10 kg)b

1

0.92 (0.73–1.17)

0.86 (0.65–1.14)

0.66

1

1.05 (0.82–1.33)

0.89 (0.69–1.16)

0.28

Model 2

 Obesity measures

  BMI (per 5 kg/m2)

1

1.02 (0.86–1.21)

1.39 (1.15–1.68)

0.004

1

1.25 (1.12–1.39)

1.45 (1.29–1.62)

0.02

  Waist circumference (per 10 cm)a

1

1.13 (0.98–1.30)

1.32 (1.12–1.56)

0.08

1

1.23 (1.11–1.35)

1.37 (1.23–1.52)

0.04

 Body composition measures

  Percent fat (per 10%)

1

1.11 (0.92–1.32)

1.37 (1.10–1.72)

0.07

1

1.20 (1.07–1.35)

1.48 (1.31–1.68)

0.004

  Fat mass (per 10 kg)b

1

1.07 (0.93–1.23)

1.28 (1.09–1.51)

0.04

1

1.18 (1.09–1.28)

1.32 (1.21–1.45)

0.04

  Fat-free mass (per 10 kg)b

1

0.93 (0.73–1.18)

0.85 (0.63–1.13)

0.61

1

1.09 (0.85–1.39)

0.93 (0.72–1.22)

0.29

Model 1: adjusted for age, education, smoking status, Socio-Economic Indexes for Areas (SEIFA), model 2: all the variables in model 1 and mental component score of SF-36

OR odds ratio, CI confidence level, BMI body mass index,

aAdjusted for fat-free mass

bCo-adjusted for each other

BMI, waist circumference, percent fat and fat mass were significantly and positively related to LBP intensity and disability for both men and women for sex-specific quartile cutoff points of these measures after adjustment for confounders (Table 4, p <0.04). For example, the adjusted OR for women for fat mass in relation to LBP intensity increased from quartile 1 to quartile 4 (Q1: reference category, Q2: OR 1.05, 95% CI 0.84–1.32; Q3: OR 1.25, 95% CI 1.00–1.57; and Q4: OR 1.78, 95% CI 1.42–2.24; p <0.001). A similar trend was observed for LBP disability (Q1: reference category, Q2: OR 1.07, 95% CI 0.79–1.45; Q3: OR 1.37, 95% CI 1.03–1.83; and Q4: OR 2.30, 95% CI 1.74–3.04; p <0.001). In contrast, fat-free mass was negatively associated with LBP intensity in women. No such association was observed for either LBP disability in women, or for LBP intensity or LBP disability in men.
Table 4

Low back pain intensity and disability in relation to measures of sex-specific quartiles

 

Q1

Q2

Q3

Q4

P for trend

Low back pain intensity, OR (95% CI)

 Men

  Obesity measures

   Body mass index

1

1.47 (1.14–1.88)

1.75 (1.36–2.25)

1.50 (1.16–1.93)

0.001

   Waist circumferencea

1

1.43 (1.10–1.84)

1.78 (1.36–2.34)

1.50 (1.12–2.00)

0.003

  Body composition measures

   Percent fat

1

1.58 (1.23–2.03)

1.64 (1.28–2.12)

1.61 (1.25–2.08)

<0.001

   Fat massb

1

1.78 (1.38–2.30)

1.91 (1.46–2.51)

1.51 (1.14–1.99)

0.02

   Fat-free massb

1

0.88 (0.68–1.14)

0.89 (0.68–1.16)

1.00 (0.76–1.33)

0.43

 Women

  Obesity measures

   Body mass index

1

1.25 (1.01–1.56)

1.25 (1.00–1.56)

1.92 (1.53–2.41)

<0.001

   Waist circumferencea

1

1.20 (0.96–1.50)

1.42 (1.13–1.78)

2.09 (1.65–2.65)

<0.001

  Body composition measures

   Percent fat

1

1.01 (0.81–1.26)

1.21 (0.96–1.51)

1.79 (1.42–2.24)

<0.001

   Fat massb

1

1.05 (0.84–1.32)

1.25 (1.00–1.57)

1.78 (1.42–2.24)

<0.001

   Fat-free massb

1

0.85 (0.68–1.06)

0.94 (0.75–1.17)

0.79 (0.63–0.99)

0.01

Low back pain disability, OR (95% CI)

 Men

  Obesity measures

   Body mass index

1

1.12 (0.82–1.53)

1.13 (0.83–1.54)

1.31 (0.96–1.79)

0.001

   Waist circumferencea

1

1.59 (1.15–2.21)

1.29 (0.91–1.83)

1.85 (1.28–2.66)

0.003

  Body composition measures

   Percentage fat

1

1.12 (0.82–1.54)

1.20 (0.87–1.64)

1.37 (1.00–1.88)

0.04

   Fat massb

1

1.20 (0.87–1.66)

1.26 (0.90–1.76)

1.45 (1.02–2.05)

0.04

   Fat-free massb

1

1.00 (0.73–1.37)

0.75 (0.54–1.05)

0.78 (0.55–1.12)

0.07

 Women

  Obesity measures

   Body mass index

1

1.36 (1.01–1.83)

1.58 (1.18–2.12)

2.56 (1.93–3.40)

<0.001

   Waist circumferencea

1

1.16 (0.86–1.58)

1.53 (1.15–2.06)

2.50 (1.86–3.34)

<0.001

  Body composition measures

   Percent fat

1

1.08 (0.80–1.45)

1.49 (1.12–1.99)

2.15 (1.63–2.85)

<0.001

   Fat massb

1

1.07 (0.79–1.45)

1.37 (1.03–1.83)

2.30 (1.74–3.04)

<0.001

   Fat-free massb

1

1.20 (0.91–1.58)

1.16 (0.88–1.54)

.92 (0.69–1.22)

0.86

Adjusted for age, sex, education, smoking status, Socio-Economic Indexes for Areas (SEIFA) and mental component score of SF-36

OR odds ratio, CI confidence level

aAdjusted for fat-free mass

bCo-adjusted for each other

Repeating the analysis in Tables 2, 3 and 4 including only those with no bodily pain at baseline (n = 3961) yielded similar results (data not shown).

Discussion

The results from this large, prospective, population-based cohort study showed that obesity measures (BMI and waist circumference), percent fat, and fat mass were positively associated with LBP intensity and disability, independent of fat-free mass. With increasing sex-specific quartiles of obesity measures, fat percent and fat mass, the risk of LBP intensity and disability increased in a linear manner. Fat-free mass was negatively associated with LBP intensity in women only, with LBP intensity reduced in a linear manner in relation to increasing sex-specific quartiles of fat-free mass, independent of the potential confounders and fat mass.

The results of the current study, that LBP is associated with overweight and obesity measures, are consistent with a recently published systematic review [6] and a meta-analysis [7] of mostly cross-sectional studies and the results from the large HUNT cross-sectional study [8]. The present study extends these findings by providing evidence from a longitudinal study, thus strengthening the evidence for this relationship. In addition we also demonstrated that obesity measures are associated with both LBP intensity and disability and that the strength of association increases with the severity of LBP, so a dose–response relationship.

The current study demonstrated a longitudinal relationship between fat mass and percent fat and LBP. The only previous data were from two cross-sectional studies [13, 14], including one that was a twin study [14]. Furthermore, this study showed a dose–response relationship of increased LBP intensity and disability in relation to increasing quartile of fat percent and fat mass measures. In contrast, the effect of fat-free mass was less consistent, with some evidence for reduced fat-free mass as a risk factor of LBP intensity in women. While most previous studies examining the association between muscle mass and LBP did not report any significant findings [2527], only one study reported that reduced trunk and lower extremity muscle mass were associated with chronic LBP measured by a negative straight leg raise test, in a subgroup of 71 women [28]. The straight leg raise test has been reported to have limited diagnostic accuracy [29]. Moreover, the study did not adjust for potential confounders, particularly the independent effect of muscle and fat mass, even though both are strongly associated with BMI and individually may simply reflect obesity. Though there is a paucity of evidence, it is possible that fat-free mass may have a beneficial effect on reducing LBP through increasing back muscle strength and back muscle endurance, which ultimately improve spinal health [30]. However, this needs further exploration.

By imposing continuous high biomechanical loading on the intervertebral disc of the lower back, obesity may result in structural modification of the disc [31, 32] that leads to greater low back pain and/or disability. Increased muscle mass having an inconsistent effect on LBP intensity and disability, and increased fat mass associated with LBP intensity and disability both in men and women suggest that the effect of obesity in the pathogenesis of LBP is mainly mediated through fat mass, despite differences in degrees of obesity. The mechanism of involvement of fat mass in the pathogenesis of LBP is likely to be multifactorial: it occurs via excess fat placing increased load on the spine; alternatively, the effect of fat mass may occur through systemic processes. There is evidence that fat mass is metabolically active and may adversely affect structures through systemic inflammatory processes induced by pro-inflammatory molecules i.e. tumour necrosis factor, adiponectin and interleukins released by adipose tissue [33] as well as decreased nutrition to the intervertebral disc via atherosclerosis [34]. Indeed, fat mass or adipose tissue secret pro-inflammatory cytokines, such as tumor necrosis factor [35] that have been shown to be more prevalent in people with modic change [36] and muscle catabolism [37]. Likewise, in patients with chronic LBP, interleukins were present in abundance in those with mild disc degeneration diagnosed by MRI [38]. It is possible that changes in disc height, modic changes and muscle destruction play a distinctive role in the degeneration of tissue surrounding the spine and thus promote development of chronic pain conditions [13]. This is supported by the finding that C-reactive protein, a marker of chronic systemic inflammation, was associated with the odds of reporting LBP [39]. Moreover, atherosclerosis, largely driven by chronic inflammation [40], may decrease blood supply to the lumbar region, in the vertebrae and surrounding muscles [34]. These might result in reduced nutrition of the lumber intervertebral disc and result in tissue degeneration [34, 41]; which is in the pathway of LBP. For example, aortic atherosclerosis was shown to increase the risk for development of disc degeneration and was associated with the occurrence of LBP in participants of the Framingham cohort after 25-year follow-up [41]. Furthermore, central and peripheral pain sensitization also has a role in LBP [42, 43]. There is increasing evidence that systemic inflammation affects central and peripheral pain sensitization [44], which may be another mechanism for the adiposity-related meta-inflammatory processes [45]. Furthermore, it has been suggested that LBP could also cause less physical activity and thereby result in obesity, however in our analysis, to eliminate the effect of less physical activity, we have adjusted all our analyses.

The results of our study should be considered within the context of its limitations. We have used bio-impedance to measure body composition. Bio-impedance is fast, inexpensive, and does not require extensive operator training or cross-validation [46], however, bio-impedance depends on body hydration, which is difficult to assess and has a strong effect on the estimation of fat mass based on bioelectric impedance analysis [47]. As a result, any between-subject variability in hydration level in this study would have resulted in attenuation of the observed association between body composition, and LBP intensity and disability. Depression has been shown to predict the development of LBP and obesity [48], thus it is a confounding factor. Though we do not have data on depression as part of the AusDiab study, we have controlled our analysis for the mental component score of the SF-36, which can correctly identify 87% of cases of depression [49]. Furthermore, participants who responded to the Chronic Pain Grade Questionnaire had better health and were of lower socio-economic status compared with those who did not respond to the questionnaire, which is likely to have underestimated the association between measures of adiposity and LBP we observed. It is also possible that residual confounding may have accounted for the associations. However in this study, we were able to adjust for most of the well-known risk factors for LBP. Strengths of our study include the large sample size and wide age range of the cohort, and use of a validated measure of LBP intensity and disability. Furthermore, in this longitudinal study we have performed subgroup analysis leaving those experiencing moderate to very severe bodily pain at baseline and have observed the similar effect. This rules out the possibility of reverse causality that suffering from LBP at study induction may have been responsible for elevated adiposity measures.

Conclusions

This study is the first large-scale, prospective, population-based cohort study demonstrating that fat mass is associated with LBP intensity and disability. This suggests both biomechanical and systemic factors associated with obesity contribute to the pathogenesis of LBP. Clarifying the mechanisms will be important for developing novel therapeutic approaches for the prevention and treatment of LBP.

Abbreviations

AusDiab: 

Australian Diabetes, Obesity and Lifestyle Study

BMI: 

Body mass index

CI: 

Confidence level

CPGQ: 

Chronic Pain Grade Questionnaire

HUNT: 

Nord-Trøndelag Health Study

LBP: 

Low back pain

MCS: 

Mental health component summary

OR: 

Odds ratio

PCS: 

Physical health component summary

SEIFA: 

Socio-Economic Indexes for Areas

SF-36: 

Short Form 36

Declarations

Acknowledgements

The AusDiab study, co-coordinated by the Baker IDI Heart and Diabetes Institute, gratefully acknowledges the support and assistance given by: B Atkins, E Barr, A Cameron, S Chadban, M de Courten, D Dunstan, S Murray, N Owen, S Tanamas, T Welborn, P Zimmet and all the study participants. We would also like to thank Dr Stephane Heritier for his suggestions on statistical analysis.

Funding

For the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study, funding support has been received from the National Health and Medical Research Council (NHMRC grant 233200), Australian Government Department of Health and Ageing, Abbott Australasia Pty Ltd, Alphapharm Pty Ltd, AstraZeneca, Bristol-Myers Squibb, City Health Centre-Diabetes Service-Canberra, Department of Health and Community Services – Northern Territory, Department of Health and Human Services – Tasmania, Department of Health – New South Wales, Department of Health – Western Australia, Department of Health – South Australia, Department of Human Services – Victoria, Diabetes Australia, Diabetes Australia Northern Territory, Eli Lilly Australia, Estate of the Late Edward Wilson, GlaxoSmithKline, Jack Brockhoff Foundation, Janssen-Cilag, Kidney Health Australia, Marian and FH Flack Trust, Menzies Research Institute, Merck Sharp & Dohme, Novartis Pharmaceuticals, Novo Nordisk Pharmaceuticals, Pfizer Pty Ltd, Pratt Foundation, Queensland Health, Roche Diagnostics Australia, Royal Prince Alfred Hospital, Sydney, Sanofi Aventis, sanofi-synthelabo, and the Victorian Government’s Operational Infrastructure Support (OIS) Program.

SMH is the recipient of AFA-ARA Heald Fellowship funded by the Australian Rheumatology Association. DU, YW and AEW are the recipients of an NHMRC Career Development Fellowship (Clinical level 1, #1011975 Clinical level 1, #1065464, and Clinical level 2, #1063574 respectively). JES is supported by an NHMRC Research Fellowship. DWD is supported by an NHMRC Senior Research Fellowship.

Availability of data and materials

All data generated or analysed during this study are included in this published article (and its Additional file 1: Table S1, S2 and Additional file 2).

Authors’ contributions

FMC, DMU, YW and AEW were involved in conception and design of the study. DMU, JES and DJM were involved in the acquisition of data. SMH, DJM and YW were involved in statistical analysis and interpretation of the data. SMH, FMC, YW, JES and AEW were involved in the interpretation of the data. SMH drafted the manuscript. All authors reviewed the manuscript with critical revision of the article for important intellectual content and approved the final manuscript. FMC took the responsibility for the integrity of the work as a whole, from inception to finished article. All authors had full access to all of the data in the study. FMC is the guarantor. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

The initial AusDiab study was approved by the International Diabetes Institute Ethics Committee and the Monash University Human Research Ethics Committee. The back pain sub-study was approved by the Alfred Health Human Research Ethics Committee. All participants provided written informed consent.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University
(2)
Baker IDI Heart and Diabetes Institute

References

  1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380(9859):2163–96.View ArticleGoogle Scholar
  2. Hoy D, March L, Brooks P, Blyth F, Woolf A, Bain C, Williams G, Smith E, Vos T, Barendregt J, et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(6):968–74.View ArticlePubMedGoogle Scholar
  3. Wynne-Jones G, Cowen J, Jordan JL, Uthman O, Main CJ, Glozier N, van der Windt D. Absence from work and return to work in people with back pain: a systematic review and meta-analysis. Occup Environ Med. 2014;71(6):448–56.View ArticlePubMedGoogle Scholar
  4. Walker BF, Muller R, Grant WD. Low back pain in Australian adults: the economic burden. Asia Pac J Public Health. 2003;15(2):79–87.View ArticlePubMedGoogle Scholar
  5. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–81.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Leboeuf-Yde C. Body weight and low back pain. A systematic literature review of 56 journal articles reporting on 65 epidemiologic studies. Spine. 2000;25(2):226–37.View ArticlePubMedGoogle Scholar
  7. Shiri R, Karppinen J, Leino-Arjas P, Solovieva S, Viikari-Juntura E. The association between obesity and low back pain: a meta-analysis. Am J Epidemiol. 2010;171(2):135–54.View ArticlePubMedGoogle Scholar
  8. Heuch I, Heuch I, Hagen K, Zwart JA. Body mass index as a risk factor for developing chronic low back pain: a follow-up in the Nord-Trondelag Health Study. Spine. 2013;38(2):133–9.View ArticlePubMedGoogle Scholar
  9. Wang Y, Simpson JA, Wluka AE, Teichtahl AJ, English DR, Giles GG, Graves SE, Cicuttini FM. Relationship between body adiposity measures and risk of primary knee and hip replacement for osteoarthritis: a prospective cohort study. Arthritis Res Ther. 2009;11(2):R31.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Lohmander LS, Gerhardsson de Verdier M, Rollof J, Nilsson PM, Engström G. Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study. Ann Rheum Dis. 2009;68(4):490–6.View ArticlePubMedGoogle Scholar
  11. Wearing SC, Hennig EM, Byrne NM, Steele JR, Hills AP. Musculoskeletal disorders associated with obesity: a biomechanical perspective. Obes Rev. 2006;7(3):239–50.View ArticlePubMedGoogle Scholar
  12. Browning RC, Kram R. Effects of obesity on the biomechanics of walking at different speeds. Med Sci Sports Exerc. 2007;39(9):1632–41.View ArticlePubMedGoogle Scholar
  13. Urquhart DM, Berry P, Wluka AE, Strauss BJ, Wang Y, Proietto J, Jones G, Dixon JB, Cicuttini FM. Young Investigator Award winner: Increased fat mass is associated with high levels of low back pain intensity and disability. Spine. 2011;36(16):1320–5.View ArticlePubMedGoogle Scholar
  14. Dario AB, Ferreira ML, Refshauge K, Sanchez-Romera JF, Luque-Suarez A, Hopper JL, Ordonana JR, Ferreira PH. Are obesity and body fat distribution associated with low back pain in women? A population-based study of 1128 Spanish twins. Eur Spine J. 2016;25(4):1188–95.View ArticlePubMedGoogle Scholar
  15. Moller DE, Flier JS. Insulin resistance — mechanisms, syndromes, and implications. N Engl J Med. 1991;325(13):938–48.View ArticlePubMedGoogle Scholar
  16. Geer EB, Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med. 2009;6 Suppl 1:60–75.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw J, de Courten M, Jolley D, McCarty DJ. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)--methods and response rates. Diabetes Res Clin Pract. 2002;57(2):119–29.View ArticlePubMedGoogle Scholar
  18. Jenkinson C, Wright L, Coulter A. Criterion validity and reliability of the SF-36 in a population sample. Qual Life Res. 1994;3(1):7–12.View ArticlePubMedGoogle Scholar
  19. Ware Jr JE, The SCD, MOS. 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.View ArticlePubMedGoogle Scholar
  20. Australian Bureau of Statistics. Information paper: census of population and housing — socio-economic indexes for areas, Australia. Canberra: Australian Bureau of Statistics; 2001.Google Scholar
  21. Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, Welborn TA. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 2003;254(6):555–63.View ArticlePubMedGoogle Scholar
  22. Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int J Obes Relat Metab Disord. 2004;28(3):402–9.View ArticlePubMedGoogle Scholar
  23. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50(2):133–49.View ArticleGoogle Scholar
  24. Smith BH, Penny KI, Purves AM, Munro C, Wilson B, Grimshaw J, Chambers WA, Smith WC. The Chronic Pain Grade questionnaire: validation and reliability in postal research. Pain. 1997;71(2):141–7.View ArticlePubMedGoogle Scholar
  25. Hebert JJ, Kjaer P, Fritz JM, Walker BF. The relationship of lumbar multifidus muscle morphology to previous, current, and future low back pain: a 9-year population-based prospective cohort study. Spine. 2014;39(17):1417–25.View ArticlePubMedGoogle Scholar
  26. Hodges P, Holm AK, Hansson T, Holm S. Rapid atrophy of the lumbar multifidus follows experimental disc or nerve root injury. Spine. 2006;31(25):2926–33.View ArticlePubMedGoogle Scholar
  27. Teichtahl AJ, Urquhart DM, Wang Y, Wluka AE, O'Sullivan R, Jones G, Cicuttini FM. Physical inactivity is associated with narrower lumbar intervertebral discs, high fat content of paraspinal muscles and low back pain and disability. Arthritis Res Ther. 2015;17(1):114.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Toda Y, Segal N, Toda T, Morimoto T, Ogawa R. Lean body mass and body fat distribution in participants with chronic low back pain. Arch Intern Med. 2000;160(21):3265–9.View ArticlePubMedGoogle Scholar
  29. Deville WL, van der Windt DA, Dzaferagic A, Bezemer PD, Bouter LM. The test of Lasegue: systematic review of the accuracy in diagnosing herniated discs. Spine. 2000;25(9):1140–7.View ArticlePubMedGoogle Scholar
  30. Lardon A, Leboeuf-Yde C, Le Scanff C. Is back pain during childhood or adolescence associated with muscle strength, muscle endurance or aerobic capacity: three systematic literature reviews with one meta-analysis. Chiropr Man Therap. 2015;23:21.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Brinckmann P, Grootenboer H. Change of disc height, radial disc bulge, and intradiscal pressure from discectomy. An in vitro investigation on human lumbar discs. Spine. 1991;16(6):641–6.View ArticlePubMedGoogle Scholar
  32. Vergroesen PP, van der Veen AJ, van Royen BJ, Kingma I, Smit TH. Intradiscal pressure depends on recent loading and correlates with disc height and compressive stiffness. Eur Spine J. 2014;23(11):2359–68.View ArticlePubMedGoogle Scholar
  33. Cao H. Adipocytokines in obesity and metabolic disease. J Endocrinol. 2014;220(2):T47–59.View ArticlePubMedPubMed CentralGoogle Scholar
  34. Kauppila LI. Atherosclerosis and disc degeneration/low-back pain--a systematic review. Eur J Vasc Endovasc Surg. 2009;37(6):661–70.View ArticlePubMedGoogle Scholar
  35. Pottie P, Presle N, Terlain B, Netter P, Mainard D, Berenbaum F. Obesity and osteoarthritis: more complex than predicted! Ann Rheum Dis. 2006;56(11):1403–5.View ArticleGoogle Scholar
  36. Ohtori S, Inoue G, Ito T, Koshi T, Ozawa T, Doya H, Saito T, Moriya H, Takahashi K. Tumor necrosis factor-immunoreactive cells and PGP 9.5-immunoreactive nerve fibers in vertebral endplates of patients with discogenic low back Pain and Modic Type 1 or Type 2 changes on MRI. Spine. 2006;31(9):1026–31.View ArticlePubMedGoogle Scholar
  37. Reid MB, Li YP. Tumor necrosis factor-alpha and muscle wasting: a cellular perspective. Respir Res. 2001;2(5):269–72.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Le Maitre CL, Freemont AJ, Hoyland JA. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther. 2005;7(4):R732–745.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Briggs MS, Givens DL, Schmitt LC, Taylor CA. Relations of C-reactive protein and obesity to the prevalence and the odds of reporting low back pain. Arch Phys Med Rehabil. 2013;94(4):745–52.View ArticlePubMedGoogle Scholar
  40. Verweij SL, van der Valk FM, Stroes ES. Novel directions in inflammation as a therapeutic target in atherosclerosis. Curr Opin Lipidol. 2015;26(6):580–5.View ArticlePubMedGoogle Scholar
  41. Kauppila LI, McAlindon T, Evans S, Wilson PW, Kiel D, Felson DT. Disc degeneration/back pain and calcification of the abdominal aorta. A 25-year follow-up study in Framingham. Spine. 1997;22(14):1642–7. discussion 1648–9.View ArticlePubMedGoogle Scholar
  42. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2–15.View ArticlePubMedGoogle Scholar
  43. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895–926.View ArticlePubMedPubMed CentralGoogle Scholar
  44. Ji RR. Peripheral and central mechanisms of inflammatory pain, with emphasis on MAP kinases. Curr Drug Targets Inflamm Allergy. 2004;3(3):299–303.View ArticlePubMedGoogle Scholar
  45. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr. 2006;83(2):461s–5s.PubMedGoogle Scholar
  46. Roubenoff R. Applications of bioelectrical impedance analysis for body composition to epidemiologic studies. Am J Clin Nutr. 1996;64(3 Suppl):459s–62s.PubMedGoogle Scholar
  47. Thompson DL, Thompson WR, Prestridge TJ, Bailey JG, Bean MH, Brown SP, McDaniel JB. Effects of hydration and dehydration on body composition analysis: a comparative study of bioelectric impedance analysis and hydrodensitometry. J Sports Med Phys Fitness. 1991;31(4):565–70.PubMedGoogle Scholar
  48. Chou L, Brady SR, Urquhart DM, Teichtahl AJ, Cicuttini FM, Pasco JA, Brennan-Olsen SL, Wluka AE. The association between obesity and low back pain and disability is affected by mood disorders: a population-based, cross-sectional study of men. Medicine (Baltimore). 2016;95(15):e3367.View ArticleGoogle Scholar
  49. Walsh TL, Homa K, Hanscom B, Lurie J, Sepulveda MG, Abdu W. Screening for depressive symptoms in patients with chronic spinal pain using the SF-36 Health Survey. Spine J. 2006;6(3):316–20.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement